serevent (serevent diskos) innöndunarduft 50 míkróg/skammt
glaxosmithkline pharma a/s - salmeterolum xínafóat - innöndunarduft - 50 míkróg/skammt
serevent accuhaler
glaxosmithkline nz limited - salmeterol xinafoate 72.5ug equivalent to 50 µg salmeterol; - powder for inhalation - 50 mcg/dose - active: salmeterol xinafoate 72.5ug equivalent to 50 µg salmeterol excipient: lactose monohydrate - serevent is indicated for long-term regular treatment of reversible airways obstruction in asthma (including nocturnal asthma and exercise-induced asthma) in adults and children who are receiving inhaled or oral corticosteroids. serevent should be used only as an adjunct to corticosteroids in the management of asthma. serevent should not be used in the treatment of acute asthmatic symptoms, or in patients whose asthma can be managed by occasional use of short-acting beta-2 agonists.
serevent inhaler cfc-free
evropa lek pharma d.o.o. beograd - Салметерол - suspenzija za inhalaciju pod pritiskom - 25mcg/doza
serevent diskus
glaxosmithkline gmbh & co. kg (8041694) - salmeterolxinafoat - einzeldosiertes pulver zur inhalation - salmeterolxinafoat (26167) 0,0725 milligramm
serevent evohaler 25 microgram pressurised inhalation suspension
ltt pharma limited - salmeterol xinafoate - pressurised inhalation suspension - 25 microgram - selective beta-2-adrenoreceptor agonists - selective beta-2-adrenoreceptor agonists - it is indicated for the regular symptomatic add-on treatment of reversible airways obstruction in patients with asthma, including those with nocturnal asthma, who are inadequately controlled on inhaled corticosteroids in accordance with current treatment guidelines. serevent is also indicated in the prevention of exercise-induced asthma
serevent diskus multidosen-inalatore a polvere
glaxosmithkline ag - salmeterolum - multidosen-inalatore a polvere - salmeterolum 50 µg per salmeteroli xinafoas, lactosum monohydricum a polvere per dosi. - bronchospasmolytikum - synthetika
serevent dosier aerosol
glaxosmithkline ag - salmeterolum - dosier aerosol - salmeterolum 25 µg di salmeteroli xinafoas, norfluranum per aerosolum per le dosi. dosi per la nave 120. - bronchospasmolytikum - synthetika
serevent 25 microgramos/inhalación, suspensión para inhalación en envase a presión
glaxosmithkline s.a. - salmeterol xinafoato - suspensiÓn para inhalaciÓn en envase a presiÓn - 25 microgramos/dosis - salmeterol xinafoato 25 microgramos - salmeterol
serevent accuhaler 50 microgramos/inhalación, polvo para inhalación
glaxosmithkline s.a. - salmeterol xinafoato - polvo para inhalaciÓn - 50 microgramos/dosis - salmeterol xinafoato 50 microgramos - salmeterol
serevent diskus multidosen-inhalateur à poudre
glaxosmithkline ag - salmeterolum - multidosen-inhalateur À poudre - salmeterolum 50 µg de salmeteroli xinafoas, lactosum monohydricum à la poussière pour la dosi. - bronchospasmolytikum - synthetika